Company Encyclopedia
View More
name
GINWA
600080.SH
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities.
3.051 T
600080.SHMarket value -Rank by Market Cap -/-

Financial Score

29/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking167/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE5.05%C
    • Profit Margin14.23%B
    • Gross Margin76.38%A
  • Growth ScoreC
    • Revenue YoY-5.35%D
    • Net Profit YoY604.96%A
    • Total Assets YoY5.21%B
    • Net Assets YoY4.17%C
  • Cash ScoreC
    • Cash Flow Margin702.79%B
    • OCF YoY-5.35%D
  • Operating ScoreD
    • Turnover0.29D
  • Debt ScoreA
    • Gearing Ratio19.09%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    GINWA: Plans to reduce holdings by no more than 2% of repurchased shares to supplement working capital

    GINWA plans to reduce its repurchased shares by no more than 2% through centralized bidding, expecting to reduce no more than 7,465,405 shares, mainly to supplement working capital. The company repurchased 20,557,582 shares from February 23, 2024, to May 22, 2024, accounting for 5.51% of the total share capital. After the reduction, the shares held in the repurchase special account will decrease to 13,092,177 shares, accounting for 3.51%

    Zhitong·
    SH
    600080
    -2.45%
    Zhitong·
    SH
    600080
    -2.45%

    GINWA: The full transfer payment and interest for 100% equity of GINWA International Hotel have been received

    GINWA announced that the company has received the remaining transfer payment of RMB 149 million and the interest of RMB 6.5231 million generated from the deferred payment from Western Investment Group Co., Ltd., totaling RMB 155 million. Thus, the company has received a total of RMB 351 million in transfer payments and interest for the 100% equity transfer of GINWA International Hotel from Western Group, and this transaction has been fully completed. Subsequently, the company will handle the relevant procedures for the release of mortgages and pledges according to the agreement

    Zhitong·
    SH
    600080
    -2.45%
    Zhitong·
    SH
    600080
    -2.45%

    GINWA: Net profit of 6.195 million yuan in the first half of 2025, a year-on-year decrease of 34.53%

    GINWA announced that in the first half of 2025, operating revenue was 241 million yuan, a year-on-year decrease of 1.90%. Net profit was 6.195 million yuan, a year-on-year decrease of 34.53%. No profit distribution or transfer of reserves to increase share capital will be conducted during the reporting period

    Zhitong·
    SH
    600080
    -2.45%
    Zhitong·
    SH
    600080
    -2.45%

    Ginwa Enterprise's Chairman Slapped With 3.5 Million Yuan Fine on Disclosure Violations

    The China Securities Regulatory Commission fined Ginwa Enterprise Group's chairman, Xing Yajiang, 3.5 million yuan for failing to disclose his residential surveillance by public security authorities from April to July 2024. This violation was only reported on August 23, 2024. The company stated that this issue will not significantly affect its daily operations, although its shares fell by less than 5%.

    Trading View·
    SH
    600080
    -2.45%
    Trading View·
    SH
    600080
    -2.45%

    Chairman of GINWA, Xing Yajiang, received a notice of case filing from the China Securities Regulatory Commission

    The chairman of GINWA, Xing Yajiang, received a notice of case filing from the China Securities Regulatory Commission on May 23, 2025, for suspected violations of information disclosure laws and regulations. This case filing is only against Xing Yajiang personally and will not affect the company's daily operations; the company is currently operating normally

    Zhitong·
    SH
    600080
    -2.45%
    Zhitong·
    SH
    600080
    -2.45%
    © 2025 Longbridge｜Disclaimer